Ayob, Ali .

HRN: 22 11 71  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/27/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/27/2022
11/02/2022
IV
500mg
Q8
Amoebiasis
Waiting Final Action 
10/28/2022
CEFTRIAXONE 1G (VIAL)
10/28/2022
11/04/2022
IV
2 Grams
Q24H
CAP-MR
Waiting Final Action 
10/28/2022
AZITHROMYCIN 500MG TABLET (TAB)
10/28/2022
10/31/2022
PO
500 Mg
OD
CAP-MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: